EMA Authorised: Ztalmy (ganaxolone) — Marinus Pharmaceuticals Emerald Limited

View source ↗

Summary

Ztalmy (ganaxolone) has been authorised by the EMA for epileptic syndromes and infantile spasms, with orphan designation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epileptic Syndromes
• Infantile Spasms

Drugs mentioned

• ZTALMY (ganaxolone)

Snippet

Status: Authorised. Therapeutic area: Epileptic Syndromes;Spasms, Infantile. MAH: Marinus Pharmaceuticals Emerald Limited. Decision date: 11/06/2026. Orphan medicine